Clinical Trial: Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07680686) titled 'Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants' on June 26.

Brief Summary: This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: Ubrogepant

IRT Oral Tablet

DRUG: Ubrogepant

ODT Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....